Trial Details
COMPLETEDBasic Information
| Clinical ID | c4454 |
|---|---|
| Identifier | NCT00496548 |
| Trial Title | Urinary Prostaglandin E Metabolite (PGE-M), A Metabolite of Prostaglandin E2 (PGE2): A Novel Biomarker of Crohn's Disease Activity |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | PROCEDURE: Fecal calprotectin|PROCEDURE: Urinary PGE-M Level |
Participant Information
| Sponsor | Vanderbilt University Medical Center |
|---|---|
| City | Nashville |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | NA |
Time Information
| Start Date | 2007-08 |
|---|---|
| Primary Completion Date | 2015-12 |
| Completion Date | 2015-12 |